US Patent Issued to The University of North Carolina at Chapel Hill on July 21 for "Treatment of CD30-positive cancer" (Singaporean, American Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,773, issued on July 21, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.).

"Treatment of CD30-positive cancer" was invented by Aung Myo (Singapore), Ivan David Horak (Singapore), Jonathan Serody (Chapel Hill, N.C.), Gianpietro Dotti (Chapel Hill, N.C.) and Barbara Savoldo (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating a CD30-positive cancer in a subject are disclosed, wherein the methods comprise administering a lymphodepleting chemotherapy and CD30-specific chimeric antigen receptor (CAR)-expressing cells."

The patent was filed on June 4, 2021, under Application No. 18/007,7...